News & Events
Missed our enlightening webinar on September 27th? Don't worry, it's now ready for your viewing pleasure! Hear from our esteemed Stanford experts as they explore the ethical challenges of incorporating generative artificial intelligence in healthcare.
Panelists: Rohini Kosoglu, Shreya Shah & Dev Dash
Moderator: Shiqin Xu
Enjoy the discussion! Stanford MCiM Panel | Unlocking Pandora's Box: Generative AI in Healthcare
- – Stanford Graduate School of Business - February 23, 2022
Insights by Stanford Business: QA Plan to Inject More Funding into the War on Antibiotic Resistance
MCiM’s Kevin Schulman and MD/MBA candidate Neil Ghandi propose federal subsidies to accelerate R&D on urgently needed antibiotics.
- – Stanford Medicine: Scope - October 12, 2020
SCOPE Blog: Q/A with MCiM Faculty Director "Investigating the generic drug industry and the health care business model"
MCiM Faculty Director and health economist Kevin Schulman unpacks the complicated workings of the U.S. health system and the generic drug industry.
- – Stanford Medicine Scope: Blog - September 1, 2020
SCOPE Blog: Faculty Director Vision for MCiM
As a health services researcher and health economist, MCiM Faculty Director Kevin Schulman has made it his mission to reduce the cost of great care. He has taught and created education programs around innovation in health care. Stanford’s MCiM is now the first master’s degree program on the West Coast focused on medicine, business, and technology.
- – Stanford Medicine News Center - September 3, 2020
Stanford Medicine Announces MCiM Launch
The School of Medicine annoucned the launching MCiM, a yearlong master’s program for medical and other professionals who want to improve health care with management skills and technology.